Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract manufacturing and development of oral solid forms for the pharmaceutical and nutraceutical industries in Italy. The company offers pharmaceuticals, dietary supplements, and other nutraceutical products, as well as medical devices in the form of powder o…
| Métrica | FF.MI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 33.3% | — |
| Operating Margin | 6.5% | 3.2% | +3.2% |
| Net Margin | 4.0% | 1.6% | +2.4% |
| FCF Margin | -1.1% | 3.5% | -4.6% |
| ROE | 7.5% | 6.9% | +0.6% |
| ROA | 3.6% | 2.0% | +1.6% |
| Current Ratio | 1.75 | 1.35 | +0.40 |
| Debt / Equity | 0.54 | 0.41 | +0.13 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✓Rentabilidad sobre activos positiva | 3.6% | — |
| ✓Flujo de caja operativo positivo | €32M | €46M |
| ✓Rentabilidad sobre activos al alza | 3.6% | 3.4% |
| ✓Caja operativa/activos supera al ROA | 11.3% | ROA 3.6% |
| ✗Menos deuda a largo plazo | 26.0% | 14.4% |
| ✓Mejor liquidez (ratio corriente) | 1.75 | 1.36 |
| ✗Sin aumentar el nº de acciones | — | — |
| –Margen bruto al alza | — | — |
| ✗Rotación de activos al alza | 0.91 | 1.01 |
| Calidad del negocio | FY25 |
|---|---|
| ✗Margen FCF > 10 % | -1.1% |
| ✗ROCE > 10 % | 7.7% |
| ✓Ventas > 5 %/año (3 años) | 6.8% |
| ✓Deuda neta/EBITDA < 3x | 1.4x |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 13.7% |
"FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A." cotiza a 6.46 EUR y tiene una capitalización bursátil de €145M. Datos fundamentales de los informes financieros anuales oficiales (ESEF) vía filings.xbrl.org; cuentas anuales, sin trimestrales.Más empresas del sector Consumo defensivo